Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs haloperidol for reducing delirium symptoms
IRCT20241224064155N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and haloperidol in delirium (2 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidinehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20241224064155N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241224064155N1.